Advancements in Non-Pharmacological Interventions for Mild Cognitive Impairment Induced by Alzheimer's Disease

Journal: Journal of Clinical Medicine Research DOI: 10.32629/jcmr.v6i1.3683

Ruoqiang Yang1, Ailin Yang1, Jinxian Wang1, Xiang Chang2

1. Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China
2. Encephalopathy Department, Xi'an Hospital of Traditional Chinese Medicine, Xi'an 710021, Shaanxi, China

Abstract

Mild cognitive impairment (MCI) associated with Alzheimer's disease (AD) represents the initial clinical manifestation of AD. Early clinical intervention for MCI is crucial for delaying or potentially reversing the progression of AD. Given the increasing prevalence of population aging, AD, as the leading cause of dementia, has imposed significant social and familial burdens. Therefore, early identification, diagnosis, and intervention of AD are of paramount importance both clinically and socially. This review aims to summarize recent advancements in the clinical diagnosis and non-pharmacological treatment of MCI derived from AD, thereby enhancing understanding of this condition, providing valuable references for clinical practice, and ultimately improving patients' cognitive function and quality of life.

Keywords

Alzheimer's disease; Mild cognitive impairment; Non-drug therapy

References

[1]Albert M S, DeKosky S T, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease[J]. Focus, 2013, 11(1): 96-106.
[2]Petersen R C, Lopez O, Armstrong M J, et al. Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology[J]. Neurology, 2018, 90(3): 126-135.
[3]Li J Q, Tan L, Wang H F, et al. Risk factors for predicting progression from mild cognitive impairment to Alzheimer’s disease: a systematic review and meta-analysis of cohort studies[J]. Journal of Neurology, Neurosurgery & Psychiatry, 2016, 87(5): 476-484.
[4]Dementia and Cognitive Disorders Group of the Neurology Section of the Chinese Medical Association. Chinese expert consensus on the diagnosis and treatment of mild cognitive impairment of Alzheimer's disease origin 2021[J]. Chinese Journal of Neurology, 2022, 55(5):20.
[5]Kawagoe T, Matsushita M, Hashimoto M, et al. Face-specific memory deficits and changes in eye scanning patterns among patients with amnestic mild cognitive impairment[J]. Scientific reports, 2017, 7(1): 14344.
[6]Kotwal A A, Kim J, Waite L, et al. Social function and cognitive status: Results from a US nationally representative survey of older adults[J]. Journal of general internal medicine, 2016, 31: 854-862.
[7]Gallagher D, Fischer C E, Iaboni A. Neuropsychiatric symptoms in mild cognitive impairment: an update on prevalence, mechanisms, and clinical significance[J]. The Canadian Journal of Psychiatry, 2017, 62(3): 161-169.
[8]de Almeida E J R, Ibrahim H J, Chitolina Schetinger M R, et al. Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer’s and Parkinson's Diseases[J]. Neurochemical Research, 2022, 47(11): 3221-3240.
[9]Liu Y, Chu J M T, Yan T, et al. Short-term resistance exercise inhibits neuroinflammation and attenuates neuropathological changes in 3xTg Alzheimer’s disease mice[J]. Journal of neuroinflammation, 2020, 17: 1-16.
[10]Montero-Odasso M, Zou G, Speechley M, et al. Effects of Exercise Alone or Combined With Cognitive Training and Vitamin D Supplementation to Improve Cognition in Adults With Mild Cognitive Impairment: A Randomized Clinical Trial[J]. JAMA Network Open, 2023, 6(7): e2324465-e2324465.
[11]Huuha A M, Norevik C S, Moreira J B N, et al. Can exercise training teach us how to treat Alzheimer’s disease?[J]. Ageing research reviews, 2022, 75: 101559.
[12]Zupo R, Griseta C, Battista P, et al. Role of plant-based diet in late-life cognitive decline: results from the Salus in Apulia Study[J]. Nutritional Neuroscience, 2022, 25(6): 1300-1309.
[13]Martínez-Huélamo M, Rodríguez-Morató J, Boronat A, et al. Modulation of Nrf2 by olive oil and wine polyphenols and neuroprotection[J]. Antioxidants, 2017, 6(4): 73.
[14]Hardman R J, Meyer D, Kennedy G, et al. Findings of a pilot study investigating the effects of Mediterranean diet and aerobic exercise on cognition in cognitively healthy older people living independently within aged-care facilities: The Lifestyle Intervention in Independent Living Aged Care (LIILAC) Study[J]. Current developments in nutrition, 2020, 4(5): nzaa077.
[15]Lilamand M, Porte B, Cognat E, et al. Are ketogenic diets promising for Alzheimer’s disease? A translational review[J]. Alzheimer's research & therapy, 2020, 12: 1-10.
[16]Xiang S, Ji J L, Li S, et al. Efficacy and safety of probiotics for the treatment of Alzheimer's disease, mild cognitive impairment, and Parkinson's Disease: a systematic review and meta-analysis[J]. Frontiers in aging neuroscience, 2022, 14: 730036.
[17]Guarnieri B, Adorni F, Musicco M, et al. Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients[J]. Dementia and geriatric cognitive disorders, 2012, 33(1): 50-58.
[18]Wang S, Zheng X, Huang J, et al. Sleep characteristics and risk of Alzheimer’s disease: a systematic review and meta-analysis of longitudinal studies[J]. Journal of Neurology, 2024: 1-12.
[19]Fernandes M, Placidi F, Mercuri N B, et al. The importance of diagnosing and the clinical potential of treating obstructive sleep apnea to delay mild cognitive impairment and Alzheimer’s disease: a special focus on cognitive performance[J]. Journal of Alzheimer's Disease Reports, 2021, 5(1): 515-533.
[20]Sherman D S, Mauser J, Nuno M, et al. The efficacy of cognitive intervention in mild cognitive impairment (MCI): a meta-analysis of outcomes on neuropsychological measures[J]. Neurophysiology review, 2017, 27: 440-484.
[21]Stern Y, Arenaza‐Urquijo E M, Bartrés‐Faz D, et al. Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance[J]. Alzheimer's & Dementia, 2020, 16(9): 1305-1311.
[22]Chapman S B, Aslan S, Spence J S, et al. Neural mechanisms of brain plasticity with complex cognitive training in healthy seniors[J]. Cerebral cortex, 2015, 25(2): 396-405.
[23]Chan A T C, Ip R T F, Tran J Y S, et al. Computerized cognitive training for memory functions in mild cognitive impairment or dementia: a systematic review and meta-analysis[J]. NPJ Digital Medicine, 2024, 7(1): 1.
[24]Son C, Park J H. Ecological effects of VR-based cognitive training on ADL and IADL in MCI and AD patients: a systematic review and meta-analysis[J]. International Journal of Environmental Research and Public Health, 2022, 19(23): 15875.
[25]Kim J H, Cho M R, Shin J C, et al. Factors contributing to cognitive improvement effects of acupuncture in patients with mild cognitive impairment: a pilot randomized controlled trial[J]. Trials, 2021, 22(1): 341.
[26]Pang Y, Shi M. Repetitive transcranial magnetic stimulation improves mild cognitive impairment associated with Alzheimer’s disease in mice by modulating the miR-567/NEUROD2/PSD95 axis[J]. Neuropsychiatric Disease and Treatment, 2021: 2151-2161.
[27]Sharbafshaaer M, Gigi I, Lavorgna L, et al. Repetitive Transcranial Magnetic Stimulation (rTMS) in Mild Cognitive Impairment: Effects on Cognitive Functions — A Systematic Review[J]. Journal of Clinical Medicine, 2023, 12(19): 6190.

Copyright © 2025 Ruoqiang Yang, Ailin Yang, Jinxian Wang, Xiang Chang

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License